Please find the attached Newspaper Intimation for the publication of December 2025 quarter financial results.
Awaiting price reaction for this filing.
Cresanto Global Limited (formerly Raymed Labs Limited) has informed BSE that its unaudited financial results for the third quarter and nine months ended December 31, 2025 were approved by the Board on February 4, 2026. The results were published as newspaper advertisements in Business Standard (English and Hindi editions) on February 6, 2026, in line with SEBI listing rules. The same results have also been made available on the company's website (www.raymedlab.com) and on BSE's website. The filing itself is a routine compliance intimation and does not include detailed financial figures for Cresanto in the body of the letter; only references to the published results.
This is a standard regulatory disclosure with no direct impact on shareholders or stock price. Investors should look at the actual published financial results in Business Standard or on the company/BSE website to assess the company's quarterly performance.